These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 32850497)

  • 1. Colon Cancer-Associated
    Abed J; Maalouf N; Manson AL; Earl AM; Parhi L; Emgård JEM; Klutstein M; Tayeb S; Almogy G; Atlan KA; Chaushu S; Israeli E; Mandelboim O; Garrett WS; Bachrach G
    Front Cell Infect Microbiol; 2020; 10():400. PubMed ID: 32850497
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models.
    Queen J; Domingue JC; White JR; Stevens C; Udayasuryan B; Nguyen TTD; Wu S; Ding H; Fan H; McMann M; Corona A; Larman TC; Verbridge SS; Housseau F; Slade DJ; Drewes JL; Sears CL
    mBio; 2021 Feb; 13(1):e0299121. PubMed ID: 35130731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAc.
    Abed J; Emgård JE; Zamir G; Faroja M; Almogy G; Grenov A; Sol A; Naor R; Pikarsky E; Atlan KA; Mellul A; Chaushu S; Manson AL; Earl AM; Ou N; Brennan CA; Garrett WS; Bachrach G
    Cell Host Microbe; 2016 Aug; 20(2):215-25. PubMed ID: 27512904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
    Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
    mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Targeting by
    Abed J; Maalouf N; Parhi L; Chaushu S; Mandelboim O; Bachrach G
    Front Cell Infect Microbiol; 2017; 7():295. PubMed ID: 28713780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.
    Wu N; Feng YQ; Lyu N; Wang D; Yu WD; Hu YF
    World J Gastroenterol; 2022 May; 28(18):1981-1995. PubMed ID: 35664967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The who, where and how of fusobacteria and colon cancer.
    Sears CL
    Elife; 2018 Mar; 7():. PubMed ID: 29533185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer.
    Chen WD; Zhang X; Zhang YP; Yue CB; Wang YL; Pan HW; Zhang YL; Liu H; Zhang Y
    Curr Med Sci; 2022 Jun; 42(3):538-547. PubMed ID: 35678912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Programmed
    Ganesan K; Guo S; Fayyaz S; Zhang G; Xu B
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31635333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in mortality in Fusobacterium necrophorum and Fusobacterium nucleatum infections detected by culture and 16S rRNA gene sequencing.
    Johannesen KM; Kolekar SB; Greve N; Nielsen XC; Barfod TS; Bodtger U
    Eur J Clin Microbiol Infect Dis; 2019 Jan; 38(1):75-80. PubMed ID: 30374684
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Hussan H; Clinton SK; Roberts K; Bailey MT
    World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Chen Y; Chen Y; Zhang J; Cao P; Su W; Deng Y; Zhan N; Fu X; Huang Y; Dong W
    Theranostics; 2020; 10(1):323-339. PubMed ID: 31903123
    [No Abstract]   [Full Text] [Related]  

  • 14. Fusobacterium nucleatum and cancer.
    Alon-Maimon T; Mandelboim O; Bachrach G
    Periodontol 2000; 2022 Jun; 89(1):166-180. PubMed ID: 35244982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusobacterium nucleatum - symbiont, opportunist and oncobacterium.
    Brennan CA; Garrett WS
    Nat Rev Microbiol; 2019 Mar; 17(3):156-166. PubMed ID: 30546113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients.
    Li YY; Ge QX; Cao J; Zhou YJ; Du YL; Shen B; Wan YJ; Nie YQ
    World J Gastroenterol; 2016 Mar; 22(11):3227-33. PubMed ID: 27004000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of 16S rRNA genes reveals reduced Fusobacterial community diversity when translocating from saliva to GI sites.
    Richardson M; Ren J; Rubinstein MR; Taylor JA; Friedman RA; Shen B; Han YW
    Gut Microbes; 2020 Nov; 12(1):1-13. PubMed ID: 33054632
    [No Abstract]   [Full Text] [Related]  

  • 18. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.
    Huang X; Hong X; Wang J; Sun T; Yu T; Yu Y; Fang J; Xiong H
    EBioMedicine; 2020 Nov; 61():103037. PubMed ID: 33039709
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Gur C; Maalouf N; Shhadeh A; Berhani O; Singer BB; Bachrach G; Mandelboim O
    Oncoimmunology; 2019; 8(6):e1581531. PubMed ID: 31069151
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study.
    Cuellar-Gómez H; Ocharán-Hernández ME; Calzada-Mendoza CC; Comoto-Santacruz DA
    Rev Gastroenterol Mex (Engl Ed); 2022; 87(3):277-284. PubMed ID: 34312118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.